Evidence map›Paper›PMID 26283706›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2015

Spectrin's chimeric E2/E3 enzymatic activity.

Steven R Goodman, Rachel Petrofes Chapa, Warren E Zimmer

Open access · greenAbstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. mBio · 2024
    Article
  5. Review
  6. Obscurin regulates ankyrin macromolecular complex formation.Journal of molecular and cellular cardiology · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. The Role of Nonerythroid SpectrinJournal of oncology · 2019
    Review
  11. Spectrin and its interacting partners in nuclear structure and function.Experimental biology and medicine (Maywood, N.J.) · 2018
    Review
  12. Immunomodulatory Effects ofFrontiers in cellular and infection microbiology · 2017
    Article
  13. Review
  14. Dysfunction of the β2-spectrin-based pathway in human heart failure.American journal of physiology. Heart and circulatory physiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Steven R GoodmanDepartment of Biochemistry and Molecular Biology, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Rachel Petrofes ChapaDepartment of Medical Physiology, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843, USA.
Warren E ZimmerDepartment of Medical Physiology, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843, USA wezimmer@medicine.tamhsc.edu.
Texas A&M Health Science Center · USSUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this minireview, we cover the discovery of the human erythrocyte α spectrin E2/E3 ubiquitin conjugating/ligating enzymatic activity and the specific cysteines involved. We then discuss the consequences when this activity is partially inhibited in sickle cell disease and the possibility that the same attenuation is occurring in multiple organ dysfunction syndrome. We finish by discussing the reasons for believing that nonerythroid α spectrin isoforms (I and II) also have this activity and the importance of testing this hypothesis. If correct, this would suggest that the nonerythroid spectrin isoforms play a major role in protein ubiquitination in all cell types. This would open new fields in experimental biology focused on uncovering the impact that this enzymatic activity has upon protein-protein interactions, protein turnover, cellular signaling, and many other functions impacted by spectrin, including DNA repair.

Indexed as

DNA RepairSignal TransductionUbiquitinationAnemia, Sickle CellAnimalsErythrocytesHumansMultiple Organ FailureSpectrinUbiquitin-Protein LigasesSpectrinUbiquitin-Protein Ligasescell signalingmultiorgan organ dysfunction syndromeproteomered blood cellSpectrinubiquitin

Identifiers

PMID26283706
PMCPMC4935279
OpenAlexW2265652283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.